What Peptides Should I Take? A 2026 Decision Framework

1. The wrong way to choose a peptide (chasing influencer stacks)

Open any peptide subreddit or biohacking podcast and you'll find the same advice: "I'm running BPC-157, TB-500, CJC-1295/Ipamorelin, NAD+, and Semax/Selank concurrently. Feeling amazing." That's not a recommendation, that's a shopping list assembled by someone with no idea what your body actually needs.

The influencer-stack problem has three failure modes:

1. No signal isolation. If you start five peptides at once and something works, or something goes wrong, you have no idea which peptide caused it. You can't titrate what you can't isolate.
2. Budget waste. Stacking four peptides before establishing single-peptide tolerance costs $300–600/month for outcomes you could get from one $80–100 vial if you matched goal to mechanism correctly.
3. Real contraindication risk. Growth hormone secretagogues are contraindicated in active cancer. Methylene blue is contraindicated with SSRIs. Stacking without a provider review skips the safety layer that matters most.

The right framework runs in the opposite direction: start with your goal, identify the mechanism that addresses it, pick the single most-evidenced peptide in that category, and add a second only after you know the first is working and safe.

2. The right way: start with your goal, then work backward to mechanism

Every peptide has a primary mechanism, a specific receptor or pathway it activates. Your job is to match the mechanism to the physiology you want to change. That means answering one question before anything else:

What is the one outcome I most want six months from now?

Not "I want to feel better overall." A specific, measurable outcome: lose 20 lbs, heal a torn rotator cuff, stop waking up at 3am, fix low libido that's affecting my relationship, improve my memory enough to notice at work.

Once you have that answer, match it to a category:

• Body fat reduction → GLP-1 category
• Injury, surgical, or gut healing → Recovery & Repair category
• Muscle, body composition → GH secretagogue category
• Focus, memory, cognitive performance → Cognitive & Brain Health category
• Low libido, arousal, desire → Sexual Health category
• Non-restorative sleep → DSIP, consider Epithalon for circadian support
• Cellular aging, energy, mitochondrial function → Longevity & Anti-Aging category
• Skin firmness, hair density → Skin & Hair topicals or GHK-Cu injectable

Then, and only then, look at specific peptides within that category, weigh evidence quality, and have a licensed prescriber confirm there are no contraindications for you specifically.

3. Decision framework: 8 goals → 8 peptide categories

The cards below summarize the top pick, dosing range, time-to-effect window, and evidence quality for each of the eight primary goal categories. Use them as a starting map, your prescriber will refine the specific dose and combination based on your intake.

4. Goal: weight loss → GLP-1 peptides

If fat loss is your primary goal, the decision is the easiest one in this entire framework, the evidence is unambiguous. GLP-1 receptor agonists (semaglutide, tirzepatide) have produced 15–22% mean body weight reduction in Phase III trials, making them the most effective pharmaceutical weight-loss tools in existence.

Semaglutide/B12

Top pick: Semaglutide/B12, starting at $25/1.2 mg vial.
Dosing range: 0.15 mg twice weekly (starter) → titrate up per tolerance.
Time to effect: Appetite reduction within 1–2 weeks; meaningful weight loss by weeks 8–12.
Evidence quality: ★★★★★, SUSTAIN and STEP trial programs, Phase III RCTs in thousands of patients.

Semaglutide mimics the GLP-1 hormone your body produces after eating, signaling fullness, slowing gastric emptying, and regulating blood sugar. RxPepsDirect's compounded version pairs it with B12 for energy support during caloric restriction. The dose ladder runs from 1.2 mg → 30 mg total per vial, your prescriber titrates based on response and side-effect tolerance.

Tirzepatide/B12

Top pick: Tirzepatide/B12, starting at $45/12 mg vial.
Dosing range: 1.5 mg twice weekly (starter) → titrate up.
Time to effect: Similar to semaglutide; dual-receptor mechanism often produces faster early satiety.
Evidence quality: ★★★★★, SURMOUNT program; 20.2% mean weight loss in SURMOUNT-5 vs semaglutide's 13.7%.

Tirzepatide adds GIP receptor activation to the GLP-1 action, a dual incretin that tends to outperform single-pathway GLP-1 agonists. It is the first-choice option for patients who want maximum weight-loss efficacy or who have plateaued on semaglutide. See the full weight loss category →

Useful stacks: Lipo-B or Lipo-C (lipotropic injections) complement GLP-1 therapy. AOD-9604 adds direct lipolysis for patients who want fat-metabolism support alongside appetite suppression. Ondansetron (Zofran) is prescribed as an adjunct for GLP-1 nausea during titration.

Key contraindications: Personal or family history of medullary thyroid carcinoma (MTC), MEN2 syndrome, active pancreatitis, severe gastroparesis, pregnancy.

5. Goal: recovery and tissue repair → BPC-157, TB-500, KPV

If you have an injury, are post-surgical, dealing with a chronic tendon or joint issue, or managing gut inflammation, the Recovery & Repair category is your starting point. The primary peptides here operate through angiogenesis (new blood vessel formation), growth factor upregulation, and systemic cell migration to injury sites.

BPC-157

Top pick: BPC-157, $80/15 mg vial.
Dosing range: 0.6 mg/day, Monday–Friday, subcutaneous or intramuscular injection near injury site.
Time to effect: Subjective improvement: 2–4 weeks; full tissue remodeling: 8–12 weeks.
Evidence quality: ★★★, Extensive preclinical data; robust open-label human clinical experience; limited RCT data in humans.

BPC-157 (Body Protection Compound) is a 15-amino acid peptide derived from a protein in human gastric juice. It works on tendons, ligaments, muscle, bone, and gut tissue. Oral capsules are available for gut-specific protocols; injectable form is preferred for systemic or musculoskeletal goals. It is the single most-prescribed non-GLP-1 peptide in compounding telehealth.

BPC-157/TB-500/KPV Stack

Top pick: BPC-157/TB-500/KPV, $120/15 mg + 15 mg + 15 mg vial.
Dosing range: 0.6/0.6 mg/day, Monday–Friday (KPV per protocol).
Time to effect: Similar to BPC-157 solo; TB-500 adds systemic anti-inflammatory action within 1–2 weeks.
Evidence quality: ★★★, Preclinical and open-label; combination is widely used in clinical practice.

TB-500 (Thymosin Beta-4) promotes systemic cell migration to injury sites and reduces inflammation beyond the local site BPC-157 targets, and KPV adds NF-κB anti-inflammatory action. Combined, these peptides address local tissue repair, systemic recovery, and inflammation at once. This three-peptide stack is the comprehensive option for post-surgical recovery, significant musculoskeletal injuries, or concurrent inflammatory conditions. Browse all recovery peptides →

6. Goal: muscle growth and body composition → CJC-1295/Ipamorelin, MK-677

Growth hormone secretagogues work by stimulating your pituitary gland to produce more of its own growth hormone, they don't add exogenous GH, they unlock more of what your body can already make. This makes them significantly safer than synthetic HGH while still producing meaningful improvements in lean mass, fat loss, and sleep quality.

CJC-1295/Ipamorelin

Top pick: CJC-1295/Ipamorelin, $100/10 mg + 10 mg vial.
Dosing range: 0.4/0.4 mg, 5 nights per week, injected in the evening.
Time to effect: Improved sleep quality: 2–4 weeks; body composition changes: 8–12 weeks.
Evidence quality: ★★★, Secretagogue mechanism well-documented; body composition benefits extrapolated from GH mechanism and human secretagogue studies.

CJC-1295 is a GHRH analog that extends the half-life of natural growth hormone-releasing hormone. Ipamorelin is a ghrelin mimetic that triggers GH pulses without raising cortisol or prolactin. Together they produce a strong, pulsatile GH release pattern that mimics natural GH peaks, particularly the deep-sleep nocturnal peak. Evening dosing aligns with and amplifies that natural pulse.

Ibutamoren (MK-677)

Top pick: Ibutamoren capsules, from $1.65/cap (12.5 mg or 25 mg).
Dosing range: 12.5–25 mg orally, once daily in the evening.
Time to effect: GH and IGF-1 elevation: within 1 week; sustained body comp changes: 8–16 weeks.
Evidence quality: ★★★, Oral ghrelin agonist with documented GH/IGF-1 elevation in human studies.

MK-677 is the only oral GH secretagogue, making it the choice for patients who prefer capsules over injections. Note: it significantly increases appetite, can cause water retention and mild fasting glucose drift, and is WADA-prohibited for competitive athletes. Blood glucose monitoring is advised. Browse all muscle growth peptides →

7. Goal: cognitive enhancement → Semax, Selank, Dihexa

Cognitive peptides are the category where evidence is thinnest relative to online enthusiasm. Most cognitive peptides have been studied in Russian clinical contexts (Semax, Selank) or in preclinical rodent models (Dihexa) rather than large Western RCTs. That doesn't mean they don't work, it means you should calibrate expectations honestly.

Semax/Selank Nasal Spray

Top pick: Semax/Selank Nasal Spray, $150/spray.
Dosing range: 1 spray per nostril daily (250 mcg/spray).
Time to effect: Acute focus effects: days; sustained anxiolytic effect: 14–21 days.
Evidence quality: ★★, Russian RCT data for anxiety and cognition; limited Western replication.

Semax is an ACTH fragment analog that upregulates BDNF and modulates dopamine/serotonin for focus and learning enhancement. Selank is a tuftsin-derived peptide that enhances GABA activity for calm without sedation. Combined: alert focus without the anxious edge that stimulants produce. Best for high-pressure professionals, students, or anyone dealing with stress-impaired cognition.

Critical flag: Flag if on lithium. Contraindicated with active psychosis. Discuss all psychiatric medications with your prescriber before starting.

Dihexa

Top pick: Dihexa capsules, from $3.50/cap (5 mg or 25 mg).
Dosing range: 5 mg/day orally, morning.
Time to effect: Anecdotal acute focus reports within days; synaptogenesis is a longer-term mechanism.
Evidence quality: ★★, Compelling preclinical HGF/MET receptor data; limited human trials.

Dihexa activates the HGF/MET receptor system, promoting synaptogenesis (new synaptic connections). Research suggests it may be millions of times more potent than BDNF at driving neural connectivity in preclinical models. Human data is thin, this is a high-curiosity, low-certainty peptide appropriate only for patients who understand the evidence gap. Browse all cognitive peptides →

8. Goal: sexual function → PT-141, Oxytocin

Sexual health peptides address desire, arousal, and emotional connection through central nervous system pathways, not vascular mechanisms. This is what makes them categorically different from PDE5 inhibitors (Viagra, Cialis), which work on blood flow and do nothing about desire itself.

PT-141 (Bremelanotide)

Top pick: PT-141 injectable, $75/10 mg vial; nasal spray, $99.
Dosing range: 0.4–2 mg per event (injectable); 2.5 mg/spray (nasal). Use 45–90 minutes before activity.
Time to effect: 45–90 minutes post-dose; effects can last 6–12 hours.
Evidence quality: ★★★★, FDA-approved as Vyleesi for HSDD in premenopausal women; male use is off-label but well-documented clinically.

PT-141 activates melanocortin-4 receptors in the hypothalamus, the neural pathways responsible for sexual desire. It works in both men and women. Unlike Viagra, it addresses the psychological and neurological components of desire, not just mechanics. Transient blood pressure elevation can occur; flag for patients with uncontrolled hypertension or cardiovascular disease.

Oxytocin (Troches and Nasal Spray)

Top picks: Oxytocin Troche 50 IU ($4/troche) or 120 IU; Oxytocin Nasal Spray ($35/15 mL).
Dosing range: 50–120 IU sublingual 30 minutes before activity; 1–2 intranasal sprays.
Time to effect: 20–40 minutes sublingual; faster via nasal route.
Evidence quality: ★★★, FDA-approved as Pitocin (obstetric use) since 1953; off-label bonding and HSDD support is well-documented.

Oxytocin enhances emotional bonding, trust, and connection, the psychological substrate that makes physical intimacy meaningful. It's often prescribed alongside PT-141 for patients whose low libido has a relational component in addition to a desire-pathway deficit. Hard contraindication during pregnancy. Browse all sexual health peptides →

9. Goal: sleep → DSIP, MOTS-c

Sleep is the most underutilized recovery tool in existence, and it is systematically degraded by stress, aging, and blue-light exposure. Peptides for sleep work through two distinct mechanisms: DSIP modulates sleep architecture directly; GH secretagogues (CJC-1295/Ipamorelin, Sermorelin) improve sleep quality indirectly by amplifying the nocturnal GH pulse that drives deep sleep.

DSIP (Delta Sleep Inducing Peptide)

Top pick: DSIP injectable, $80/10 mg vial.
Dosing range: 0.1–0.3 mg/day subcutaneous, starting low.
Time to effect: Sleep architecture changes: 1–3 weeks.
Evidence quality: ★★, Primarily 1981–1985 IV clinical trials; modern subcutaneous data is limited; 40–50% non-responder rate reported.

DSIP is not a sedative. It modulates delta wave (slow-wave, deep sleep) activity and regulates cortisol circadian patterns without dependency risk. The non-responder rate is significant, expect your prescriber to discuss realistic expectations. If deep sleep architecture is the goal, CJC-1295/Ipamorelin is often the better-evidenced choice with additional body-composition benefits.

Note on MOTS-c for sleep: MOTS-c is primarily a longevity and metabolic peptide but is occasionally used in sleep protocols due to its circadian rhythm regulation effects through AMPK signaling. It appears in the Lean Stack for body composition and is an adjacent tool for patients with metabolic-driven sleep disruption.

10. Goal: longevity and cellular energy → NAD+, SS-31, MOTS-c

Longevity peptides target the fundamental mechanisms of cellular aging: mitochondrial dysfunction, declining NAD+ levels, telomere shortening, and oxidative stress. The evidence base is strong in preclinical models and growing in humans, but "longevity" is the goal where tempered expectations matter most. These peptides optimize the cellular environment. None of them have proven lifespan extension in humans.

NAD+ Injectable

Top pick: NAD+ Injectable, $100/1,000 mg vial (10 mL, 100 mg/mL).
Dosing range: 20–100 mg/day subcutaneous injection, Monday–Friday.
Time to effect: Energy/cognitive clarity improvements: 2–4 weeks; cellular benefits accumulate over 8–16 weeks.
Evidence quality: ★★★, Robust mechanism; growing human clinical literature; not proven to extend human lifespan.

NAD+ is the most-marketed longevity molecule for good reason: it's the coenzyme that powers cellular energy production, DNA repair, and sirtuin (longevity protein) activation. Levels decline approximately 50% between ages 40 and 60. Injectable NAD+ bypasses the significant digestive degradation that limits oral supplements like NMN and NR, at roughly one-tenth the cost per effective mg of IV drip therapy.

Elamipretide (SS-31)

Top pick: SS-31, $100/75 mg vial.
Dosing range: 3 mg/day subcutaneous injection.
Time to effect: Energy production changes: 4–8 weeks; full cellular effect: 8–16 weeks.
Evidence quality: ★★★, Strongest mechanism in the mitochondrial category; Phase III program for Barth syndrome; ReCLAIM-2 missed primary endpoint.

SS-31 targets cardiolipin in the inner mitochondrial membrane, stabilizing the electron transport chain that produces cellular energy and reducing reactive oxygen species (ROS). It has the most elegant mechanism of any mitochondria-targeted peptide. The Phase III miss in a rare disease (Barth syndrome) doesn't diminish its utility for age-related mitochondrial decline.

MOTS-c

Top pick: MOTS-c, $80/10 mg vial (standard) or $130/50 mg (high-dose).
Dosing range: 0.4–2 mg/day, Monday–Friday.
Time to effect: Metabolic flexibility and exercise capacity: 4–8 weeks.
Evidence quality: ★★★, Strong rodent data; growing human metabolic data; WADA-prohibited for competitive athletes since January 1, 2025.

MOTS-c is encoded within the mitochondrial genome, one of the only known mitochondrial-derived peptides. It activates AMPK (the cellular energy sensor) to regulate glucose and fat metabolism and improve metabolic flexibility. It's an adjacent tool to NAD+ and SS-31 in longevity protocols.

11. Goal: skin and hair → GHK-Cu, Sermorelin

Skin and hair goals are best served through topical prescription-strength peptides, not OTC serums and not systemic injections as a first choice. The concentration gap between compounded prescription topicals and mass-market OTC copper peptide serums is 30–60x: prescription GHK-Cu formulations run 1–3%, while The Ordinary, Biossance, and NIOD disclose 0.05–0.1%.

GHK-Cu Topicals

Top picks: GHK-Cu 1% Hair Restoration Solution ($100/30 mL), Cashmere Cream 3% GHK-Cu ($45/30 g), GHK-Cu SNAP-8 Niacinamide Serum ($140/30 mL).
Dosing: Apply daily per protocol; hair solution: 1 mL to scalp, evening; face creams and serums: pea-sized to face and neck.
Time to effect: Skin firmness: 4–8 weeks; hair density: 90–180 days.
Evidence quality: ★★★, Human RCT support for topical GHK-Cu in wound healing and skin texture; hair density evidence from small clinical series.

GHK-Cu is a naturally occurring copper-binding tripeptide that activates over 4,000 genes involved in tissue repair and regeneration. Levels decline with age. Topically, it drives collagen and elastin synthesis, upregulates VEGF for follicular support, and shifts gene expression patterns toward a younger cellular profile. Injectable GHK-Cu is available as an add-on for systemic longevity protocols but is not the primary route for skin and hair goals.

Sermorelin for Skin and Hair

Sermorelin (GHRH analog, $80/15 mg vial) is listed in the Muscle Growth category but produces significant skin and hair benefits as a secondary effect of GH stimulation, GH drives collagen production, skin thickness, and hair follicle cycling. Patients on Sermorelin or CJC-1295/Ipamorelin often report skin quality improvements at 12–16 weeks alongside body composition changes.

12. The honest answer most influencers won't give: most people don't need a peptide

Before you spend $80–600/month on peptides, run through this checklist:

• Sleep: Are you sleeping 7–9 hours in a dark, cold room? If not, DSIP won't fix a lifestyle problem.
• Protein: Are you eating 0.7–1 g/lb of bodyweight? CJC-1295/Ipamorelin won't add muscle if there's no raw material.
• Resistance training: Are you lifting progressively 3–4 days/week? No peptide substitutes for mechanical load in muscle growth.
• Stress: Is your cortisol chronically elevated? Semax/Selank might help focus, but persistent high cortisol will blunt any peptide's effect.
• Metabolic health: Is your fasting glucose, insulin sensitivity, and inflammatory load optimized? GLP-1s work better in patients who've already addressed diet quality.

Peptides are tools that accelerate specific biological processes. They don't replace the foundational variables that those processes depend on. If you have an acute injury with diagnosed tendon damage, BPC-157 is a legitimate tool. If you have a BMI > 30 and documented metabolic dysfunction, GLP-1 therapy has unambiguous clinical justification. If you're a healthy 28-year-old who sleeps poorly because you scroll your phone until 1 AM, no peptide will fix that.

The RxPepsDirect clinical review exists partly to catch this. A licensed prescriber will ask what you've already tried, what your labs look like, and whether the peptide you're requesting actually maps to the problem you're describing.

13. How RxPepsDirect's clinical review works

Every RxPepsDirect prescription goes through a licensed provider review, no exceptions, no self-service. Here's what the process looks like:

1. Online intake: You complete a detailed health history form covering your goal, current medications, relevant diagnoses, and any contraindications relevant to your target peptide category.
2. Clinical review ($39 visit fee): A licensed prescriber licensed in your state reviews your intake asynchronously. For complex cases or contraindication flags, a synchronous telehealth visit may be required.
3. Prescription issued: If approved, the prescriber sends a patient-specific script to Optimal Balance Pharmacy (OBP, practice ID 1042913), a 503A sterile compounding pharmacy.
4. Pharmacy fill and ship: OBP compounds your peptide, runs per-batch sterility (ScanRDI) and potency (USP <621>) testing, and ships your prescription FedEx overnight pre-reconstituted, no bacteriostatic water required.
5. Follow-up: Your prescriber is available for follow-up questions, dose adjustments, and protocol changes through the patient portal.

RxPepsDirect currently serves patients in 28 states and Washington DC. Check your state eligibility before beginning the intake process. See pricing → | Browse all peptide categories →